Asia-Pacific Wound Care Market Outlook, 2031

2026

Asia-Pacific Wound Care Market Outlook, 2031

The Asia-Pacific Wound Care Market is segmented By Product Type (Advanced Wound Care, Surgical Wound Care, Traditional/Basic Wound Care, Others); By Wound Type (Chronic Wounds, Acute Wounds); By End User (Hospitals & Clinics, Home Healthcare, Others); By Distribution Channel (Direct Sales, Retail Pharmacies, Others).

Bonafide Research
22-01-2026
Pages : 93
Figures : 8
Tables : 29
Region : Asia-Pacific
Category : Lifescience
Healthcare

Schedule a Call

Buy Now Get Free sample

Asia-Pacific wound care market is projected to grow above 6.88% CAGR (2026–2031), supported by rising healthcare capacity and local production.

Historical Period2020-2024
Base Year2025
Forecast Period2026-2031
CAGR (2026-2031) 6.88%
Largest MarketChina
Fastest Market India
Format

Featured Companies

1. Medline Industries, LP
2. 3M Company
3. Cardinal Health, Inc.
4. Medtronic plc
5. Smith & Nephew plc
6. Essity AB
More...

Highend Report

Highend report of this product is available

View

New Report Guarantee

If you purchase this report now and we update it in next 100 days, get it free!

Wound Care Market Analysis

The aim of the wound care sector in Asia Pacific is to stop infections, encourage quick healing, and minimize complications from acute, chronic, surgical, and traumatic wounds. Worldwide, wound care has shifted from conventional methods like cotton gauze, herbal antiseptics, and dry bandaging to modern approaches that focus on moist wound healing and innovative therapies. In Asia Pacific, the uptake has shown a two-fold pattern established markets like Japan, Australia, South Korea, and Singapore embraced advanced wound care sooner through hospital-led advancements, while emerging nations initially depended on affordable traditional solutions. As time passed, greater healthcare investments broadened product options to include foams, hydrocolloids, alginates, antimicrobial dressings, negative pressure wound therapy NPWT, and bioactive products. Key users consist of surgeons, nurses, community health workers, caregivers, and patients. Wound care is utilized in hospitals, outpatient clinics, rural health facilities, and increasingly in home care situations, especially where access to hospitals is limited. From a technical perspective, wound care items control fluid leakage, keep an ideal moisture level, prevent microbial intrusion, and aid in tissue regeneration vital in Asia Pacific where a high number of patients raises infection risks. Advances in technology aim for affordability and scalability, such as easier NPWT devices, antimicrobial dressings made with locally sourced materials, and cost-effective manufacturing. Regional research and development initiatives focus on affordable innovation, collaboration between private and public sectors, and local production to decrease reliance on imports. Regulatory bodies like Japan’s PMDA, China’s NMPA, India’s CDSCO, and ASEAN Medical Device Directive ensure the safety, quality, and clinical efficiency of products. These certifications foster trust in various markets, encourage standardization, and facilitate the broader acceptance of wound care products throughout Asia Pacific. According to the research report, " Asia - Pacific Wound Care Market Outlook, 2031," published by Bonafide Research, the Asia - Pacific Wound Care market is anticipated to grow at more than 6.88% CAGR from 2026 to 2031. Recent changes in the Asia Pacific wound care industry are influenced by an increase in healthcare capacity, growth in domestic production, and initiatives in public health led by governments. Nations like China and India are heavily investing in hospital facilities, medical device parks, and local manufacturing through programs such as "Make in India" and China's modernization efforts in healthcare. Innovation centers located in Japan, South Korea, and Singapore are concentrating on smart bandages, regenerative treatments, and digital monitoring for wounds, while countries in Southeast Asia are focusing on affordable advanced dressings. Public health programs that aim to manage diabetes, enhance surgical safety, and control infections are driving the demand for wound care items. Key players in the region and include Smith & Nephew, 3M, Mölnlycke, Coloplast, and Convatec, as well as strong regional companies like Hartmann Asia, Winner Medical, and Nipro. These businesses provide a variety of advanced dressings, antimicrobial products, NPWT systems, and budget-friendly wound management items. The market is rapidly growing due to the rising prevalence of chronic diseases, especially wounds related to diabetes, an increase in surgical procedures, and better access to healthcare. The expansion of health insurance and rural healthcare initiatives further enhances market growth. As infrastructure improves and knowledge of advanced wound care increases, the Asia Pacific region shows great long-term growth potential for both international and local companies.

to Download this information in a PDF

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Market Dynamic

Market Drivers • Growing occurrence of chronic diseases: Chronic conditions such as diabetes, heart problems, and obesity are becoming more prevalent in the Asia Pacific area due to lifestyle changes, urban growth, and an aging population. These illnesses frequently lead to issues like diabetic foot ulcers, pressure sores, and wounds that heal slowly, which increases the need for advanced wound care products. With the rise in chronic wounds, healthcare facilities and home care services are on the lookout for new solutions to enhance patient outcomes. This ongoing rise in chronic wound situations is a key contributor to the expansion of the market. • Enhancing healthcare infrastructure and medical travel: Various nations in the Asia Pacific, including India, Thailand, and Singapore, are enhancing their medical infrastructure with modern hospitals and specialized care facilities. This growth, combined with the rise in medical tourism, makes advanced wound care items more accessible to local and international patients alike. Hospitals are allocating resources to high-quality wound management systems to satisfy increasing patient needs. The greater presence of specialized clinics and treatment centers directly boosts the market for advanced dressings and therapies. Market Challenges • High expenses and limited insurance coverage: Advanced wound care items are often costly and may not receive full coverage from insurance or national health programs. This restricts accessibility, particularly in lower-income and middle-income countries in the region. Patients frequently must pay from their own pockets, which may lower adoption rates. High costs also create difficulties for hospitals and clinics trying to maintain quality care while adhering to budget limitations. This financial hurdle hinders the widespread adoption of advanced wound care technologies. • Lack of skilled wound care professionals: Effective use of advanced wound care products necessitates trained personnel. In many APAC countries, there is a deficiency of wound care nurses and specialists, particularly in rural locales. Insufficient training programs and limited knowledge among healthcare practitioners can lead to inadequate treatment. This issue impacts both hospitals and home care services, restricting the efficient use of innovative wound care solutions. Market Trends • Embracing cutting-edge technologies: The market is experiencing a transition from standard dressings to advanced solutions such as bioactive dressings, hydrocolloids, foam dressings, and smart dressings equipped with sensors. These modern technologies not only facilitate quicker healing but also enable remote monitoring of wound conditions. Innovations in regenerative treatments and nanotechnology are also shaping product development. More hospitals and clinics are adopting these advanced methods to improve care quality, shorten hospital stays, and enhance patient outcomes. • Growth of home-based and digital wound care options: There is an increasing trend towards at-home wound care supported by digital tools, mobile applications, and telemedicine platforms. Patients can now receive remote monitoring and advice from healthcare professionals, which reduces the frequency of hospital visits. This trend is fueled by convenience, cost-effectiveness, and greater awareness of self-managed care. Digital wound assessment tools and AI-driven monitoring assist in identifying complications early, which further promotes the use of advanced wound care outside of hospital settings.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Wound Care Segmentation

By Product Type	Advanced Wound care
	Surgical Wound Care
	Traditional/Basic Wound Care
	Others (Wound Therapy Devices, Active Wound Care/Bioactives)
By Wound Type	Chronic Wounds
	Acute Wounds
By End User	Hospitals & clinics
	Home Healthcare
	Others (Long-term Care Facilities, Nursing Homes, Military & Trauma Centers, Ambulatory Surgical Centers)
By Distribution Channel	Direct Sales
	Retail Pharmacies
	Others (Online Sales / E-commerce, Distributors)
Asia-Pacific	China
	Japan
	India
	Australia
	South Korea

Advanced wound care items take the lead in the Asia Pacific market because of the increasing rates of chronic wounds and the growing use of new dressing technologies. The Advanced Wound Care sector accounts for the largest portion of the Asia Pacific wound treatment market mainly due to the rising prevalence of long-lasting illnesses like diabetes, obesity, and heart diseases, which lead to more cases of wounds that do not heal, such as diabetic foot ulcers and pressure ulcers. Nations such as India, China, Japan, and South Korea are witnessing swift urban growth, older demographics, and lifestyle changes that enhance the occurrence of chronic wounds, thus increasing the demand for effective and superior wound treatment options. Advanced wound care products, such as hydrocolloid, foam, alginate, and film dressings, are commonly chosen in hospitals and specialty clinics for their enhanced capability to sustain a moist environment for wounds, prevent infections, and speed up healing when compared to conventional wound care items. Furthermore, the rising understanding among healthcare workers and patients about the advantages of advanced wound care, along with government efforts to improve healthcare systems, has boosted their use in both urban and semi-urban areas. Innovations in technology, such as antimicrobial and bioactive dressings, have ally improved the appeal of this segment by offering better clinical results and shorter hospital stays. Moreover, the rise of home healthcare and digital monitoring solutions enables patients to utilize advanced wound care products outside of hospitals, reinforcing their prominent position in the market. Financial and reimbursement issues are becoming less significant in key APAC markets because of increasing healthcare spending, medical tourism, and local manufacturing that helps lower costs. Chronic wounds are the most prevalent issue in the North American wound care sector because of the high rates of diabetes, an older population, and effective usage of advanced management methods for long-term care of wounds. In North America, the largest and rapidly expanding area within the wound care industry consists of chronic wounds, which include diabetic foot ulcers, venous leg ulcers, and pressure injuries. The increasing rates of diabetes and obesity in the United States and Canada have led to a greater number of individuals at risk for chronic wounds, as these health issues hinder natural healing. Furthermore, the aging population in this region shows a higher susceptibility to pressure ulcers and venous ulcers because of decreased mobility and circulation problems. The well-developed healthcare system, heightened awareness of the risks associated with chronic wounds, and widespread acceptance of cutting-edge treatments like negative pressure wound therapy, bioengineered skin substitutes, and specialized dressings contribute to market expansion. Comprehensive insurance coverage and reimbursement policies enhance patient access to prolonged wound care, supporting the use of new treatment options. The interplay of demographic changes, the burden of chronic diseases, technology adoption, and favorable healthcare policies positions chronic wounds as the most significant and expanding segment in North America's wound care market, with healthcare providers focusing on minimizing complications, enhancing outcomes, and reducing hospital readmissions. The Asia Pacific wound care market is primarily led by hospitals and clinics because of their sophisticated infrastructure, a high volume of patients, and a preference for evidence-based wound care solutions. The largest user group in the Asia Pacific wound care market is formed by hospitals and clinics, as they are the main places for diagnosing, treating, and handling both acute and chronic wounds. In nations such as India, China, Japan, and South Korea, the increase in chronic health issues like diabetes, obesity, and heart diseases has led to a rise in patients requiring expert wound care attention. These hospitals and specialized clinics are outfitted with advanced medical systems, skilled healthcare staff, and the capability to utilize modern wound care technologies, including hydrocolloids, foam bandages, and antimicrobial dressings. These facilities create a controlled space where medical professionals can closely observe the healing of wounds, manage potential complications, and enhance treatment results, which makes them the preferred option for patients and healthcare practitioners alike. Furthermore, regional government programs designed to enhance medical facilities and healthcare access have contributed to the growth of well-equipped hospitals and clinics, particularly in cities and suburban areas. Hospitals also play a vital role in guiding patients and their families on effective wound care practices, which further solidifies their position as the leading end-user segment. The trend toward hospital-based care is influenced by the requirement for sterile conditions, prompt clinical responses to infections, and access to advanced treatments that are impractical to perform at home. Moreover, collaborations among hospitals, product manufacturers, and distributors guarantee a consistent availability of quality wound care items, increasing their usage. All these elements combine to establish hospitals and clinics as the leading and most significant user group in the Asia Pacific wound care market, blending high patient numbers, advanced infrastructure, and professional knowledge to promote market expansion. Direct sales dominate the Asia‑Pacific wound care market as leading healthcare institutions and government facilities choose direct buying to guarantee dependable supply, personalized service, and robust local support. In the Asia-Pacific wound care sector, direct sales are the leading distribution method owing to the region's particular healthcare environment and purchasing habits. Large hospitals, both public and private, especially in countries like China, Japan, India, and Southeast Asia, typically prefer to interact directly with manufacturers and key suppliers to ensure a steady availability of products for high-demand wound care applications. Direct sales channels enable these healthcare institutions to negotiate customized agreements, obtain practical product training, and enjoy comprehensive clinical assistance, especially crucial for advanced wound care solutions such as hydrocolloid dressings, antimicrobial items, and negative pressure wound therapy devices. Numerous wound care manufacturers also dedicate significant resources to field teams and local offices to establish strong connections with clinicians and hospital administrators, making direct sales the preferred, trusted method for procurement. This strategy assists hospitals in simplifying their purchasing processes, lowering the number of intermediaries, and frequently benefiting from improved pricing or service assurances, which is particularly useful in nations where supply chain dependability may fluctuate. Moreover, government purchasing frameworks in various Asia-Pacific nations prefer direct vendor registration and institutional tenders, further solidifying this channel's supremacy. In regions where regulatory frameworks and product approval processes are developing, direct sales enable manufacturers to quickly roll out new wound care advancements and provide immediate education that fosters hospital adoption. For smaller clinics and specialized wound centers, direct engagement with suppliers improves discussions regarding specific patient requirements and product effectiveness. All these elements contribute to maintaining direct sales as the principal distribution method in the Asia-Pacific wound care market, reflecting a preference for strong vendor ties, personalized service, and consistent supply continuity in a diverse and rapidly evolving healthcare landscape.

to Download this information in a PDF

Wound Care Market Regional Insights

China is at the forefront of the Asia Pacific wound care market because of its vast patient population, sophisticated healthcare system, and strong governmental support for contemporary wound care practices. China has taken a leading role in the Asia Pacific wound care market, thanks to a mix of demographic, healthcare, and economic influences. The nation boasts the largest population in the area, with a fast-growing older demographic that faces higher risks of chronic ailments such as diabetes, heart disease, and pressure sores, leading to a rise in wounds needing medical attention. Moreover, increased urban living and changing lifestyles have resulted in a higher occurrence of both chronic and immediate wounds, heightening the demand for innovative wound care products and techniques. Over the last ten years, China's healthcare framework has expanded significantly, driven by government funding directed towards hospitals, specialized wound care facilities, and training programs for medical staff. These efforts ensure that cutting-edge wound care items, like bioactive dressings, foam products, and negative-pressure wound therapy devices, are accessible in both urban and suburban communities. Additionally, the Chinese authorities have introduced initiatives aimed at improving access to high-quality medical equipment, expediting regulatory processes, and promoting local production of wound care supplies, boosting both cost-effectiveness and usage rates. The increasing number of medical device manufacturers and suppliers within China guarantees efficient distribution and access to products throughout various areas. Growing awareness among healthcare providers and patients about the advantages of advanced wound care options, along with a rise in outpatient and home-based treatment services, reinforces the country’s top position. , China’s extensive patient base, strong healthcare foundation, government backing, and growing use of progressive wound care technologies solidify its status as the leading market in the Asia Pacific, contributing to both volume and revenue growth.

to Download this information in a PDF

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Companies Mentioned

Medline Industries, LP
3M Company
Cardinal Health, Inc.
Medtronic plc
Smith & Nephew plc
Essity AB
B. Braun Melsungen AG
Baxter International Inc.
Molnlycke Health Care AB
Convatec Group PLC
Coloplast Corporation
Lohmann & Rauscher International

1. Executive Summary
2. Market Dynamics
2.1. Market Drivers & Opportunities
2.2. Market Restraints & Challenges
2.3. Market Trends
2.4. Supply chain Analysis
2.5. Policy & Regulatory Framework
2.6. Industry Experts Views
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. Market Structure
4.1. Market Considerate
4.2. Assumptions
4.3. Limitations
4.4. Abbreviations
4.5. Sources
4.6. Definitions
5. Economic /Demographic Snapshot
6. Asia-Pacific Wound Care Market Outlook
6.1. Market Size By Value
6.2. Market Share By Country
6.3. Market Size and Forecast, By Product Type
6.4. Market Size and Forecast, By Wound Type
6.5. Market Size and Forecast, By End User
6.6. Market Size and Forecast, By Distribution Channel
6.7. China Wound Care Market Outlook
6.7.1. Market Size by Value
6.7.2. Market Size and Forecast By Product Type
6.7.3. Market Size and Forecast By Wound Type
6.7.4. Market Size and Forecast By End User
6.7.5. Market Size and Forecast By Distribution Channel
6.8. Japan Wound Care Market Outlook
6.8.1. Market Size by Value
6.8.2. Market Size and Forecast By Product Type
6.8.3. Market Size and Forecast By Wound Type
6.8.4. Market Size and Forecast By End User
6.8.5. Market Size and Forecast By Distribution Channel
6.9. India Wound Care Market Outlook
6.9.1. Market Size by Value
6.9.2. Market Size and Forecast By Product Type
6.9.3. Market Size and Forecast By Wound Type
6.9.4. Market Size and Forecast By End User
6.9.5. Market Size and Forecast By Distribution Channel
6.10. Australia Wound Care Market Outlook
6.10.1. Market Size by Value
6.10.2. Market Size and Forecast By Product Type
6.10.3. Market Size and Forecast By Wound Type
6.10.4. Market Size and Forecast By End User
6.10.5. Market Size and Forecast By Distribution Channel
6.11. South Korea Wound Care Market Outlook
6.11.1. Market Size by Value
6.11.2. Market Size and Forecast By Product Type
6.11.3. Market Size and Forecast By Wound Type
6.11.4. Market Size and Forecast By End User
6.11.5. Market Size and Forecast By Distribution Channel
7. Competitive Landscape
7.1. Competitive Dashboard
7.2. Business Strategies Adopted by Key Players
7.3. Key Players Market Positioning Matrix
7.4. Porter's Five Forces
7.5. Company Profile
7.5.1. Smith & Nephew plc
7.5.1.1. Company Snapshot
7.5.1.2. Company Overview
7.5.1.3. Financial Highlights
7.5.1.4. Geographic Insights
7.5.1.5. Business Segment & Performance
7.5.1.6. Product Portfolio
7.5.1.7. Key Executives
7.5.1.8. Strategic Moves & Developments
7.5.2. B. Braun Melsungen SE
7.5.3. Baxter International Inc
7.5.4. 3M Company
7.5.5. Medtronic Inc.
7.5.6. Convatec Group plc
7.5.7. Medline Inc.
7.5.8. Cardinal Health, Inc
7.5.9. Mölnlycke Health Care AB
7.5.10. Essity AB
7.5.11. Lohmann & Rauscher International
7.5.12. Integra LifeSciences Holdings Corporation
8. Strategic Recommendations
9. Annexure
9.1. FAQ`s
9.2. Notes
9.3. Related Reports
10. Disclaimer

Table 1: Influencing Factors for Wound Care Market, 2025
Table 2: Top 10 Counties Economic Snapshot 2024
Table 3: Economic Snapshot of Other Prominent Countries 2022
Table 4: Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars
Table 5: Asia-Pacific Wound Care Market Size and Forecast, By Product Type (2020 to 2031F) (In USD Billion)
Table 6: Asia-Pacific Wound Care Market Size and Forecast, By Wound Type (2020 to 2031F) (In USD Billion)
Table 7: Asia-Pacific Wound Care Market Size and Forecast, By End User (2020 to 2031F) (In USD Billion)
Table 8: Asia-Pacific Wound Care Market Size and Forecast, By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 9: China Wound Care Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 10: China Wound Care Market Size and Forecast By Wound Type (2020 to 2031F) (In USD Billion)
Table 11: China Wound Care Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 12: China Wound Care Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 13: Japan Wound Care Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 14: Japan Wound Care Market Size and Forecast By Wound Type (2020 to 2031F) (In USD Billion)
Table 15: Japan Wound Care Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 16: Japan Wound Care Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 17: India Wound Care Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 18: India Wound Care Market Size and Forecast By Wound Type (2020 to 2031F) (In USD Billion)
Table 19: India Wound Care Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 20: India Wound Care Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 21: Australia Wound Care Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 22: Australia Wound Care Market Size and Forecast By Wound Type (2020 to 2031F) (In USD Billion)
Table 23: Australia Wound Care Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 24: Australia Wound Care Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 25: South Korea Wound Care Market Size and Forecast By Product Type (2020 to 2031F) (In USD Billion)
Table 26: South Korea Wound Care Market Size and Forecast By Wound Type (2020 to 2031F) (In USD Billion)
Table 27: South Korea Wound Care Market Size and Forecast By End User (2020 to 2031F) (In USD Billion)
Table 28: South Korea Wound Care Market Size and Forecast By Distribution Channel (2020 to 2031F) (In USD Billion)
Table 29: Competitive Dashboard of top 5 players, 2025

Figure 1: Asia-Pacific Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 2: Asia-Pacific Wound Care Market Share By Country (2025)
Figure 3: China Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 4: Japan Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 5: India Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 6: Australia Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 7: South Korea Wound Care Market Size By Value (2020, 2025 & 2031F) (in USD Billion)
Figure 8: Porter's Five Forces of Global Wound Care Market

Wound Care Market Research FAQs

The Asia Pacific Disposable Wound Management Products market is expected to grow with 6.57% CAGR by 2023-28.

Demand for these products is influenced by factors such as the aging population, increasing surgical procedures, rising awareness of wound care, and improvements in healthcare infrastructure.

Major companies in this market include 3M Company, Johnson & Johnson, Smith & Nephew, Molnlycke Health Care, and ConvaTec Group, among others. Market dynamics may have changed since my last update.

Yes, regulatory requirements can vary by country in the Asia Pacific region. Manufacturers and distributors must adhere to local regulations and obtain necessary approvals and certifications for their products.

Some trends include the adoption of advanced wound care technologies, the development of antimicrobial wound dressings, and a shift toward eco-friendly and sustainable wound care products.

This market's growth is linked to the rising number of diabetes cases, an older population, and increasing recognition of chronic wound care management by healthcare professionals.

Chronic wounds, including diabetic foot ulcers and pressure sores, are the most common due to the increasing patient population with diabetes and older individuals facing mobility and circulation issues.

Hospitals and government entities favor direct sales for their consistent supply, practical product education, and robust clinical support from suppliers.

Key aspects driving demand include greater hospital use of negative pressure wound therapy, bioengineered skin products, antimicrobial dressings, government healthcare programs.

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted